Use of the complex between prostate specific antigen and alpha I protase inhibitor for screening prostate cancer;Utilisation du complexe PSA-inhibiteur de l'alphalprotéase pour le dépistage du cancer prostatique

Progres en Urologie

Volumn 11, Issue 1, 2001, Pages 182-183

  Finne, P ^a   Zhang, W M ^a   Auvinen, A ^a   Leinonen, J ^a   Maattanen, L ^a   Rannikko, S ^a   Tammela, T L ^a   Stenman, U H ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0347121842     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. BECKER C., PIIRONEN T., PETTERSSON K., BJORK T., WOJNO K.J., OESTERLING J.E., LILJA H.: Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum. J Urol, 2000, 163, 311-316.
2. BRAWER M.K., MEYER G.E., LETRAN J.L., BANKSON D.D., MORRIS D.L., YEUNG K.K., ALLARD W.J.: Measurement of complexed PSA improves specificity for early detection of prostate cancer. Urology, 1998, 52, 372-378.
3. PARTIN A.W., MURPHY G.P., BRAWER M.K.: Report on Prostate Cancer Tumor Marker Workshop 1999. Cancer, 2000, 88, 955-963.
4. ZHANG W.M., FINNE P., LEINONEN J., VESALAINEN S., NORDLING S., STENMAN U.H.: Measurement of the complex between prostate-specific antigen and alphal- protease inhibitor in serum. Clin Chem, 1999, 45, 814-821.